• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大鼠肝脏中铁氧化物颗粒的清除:水合粒径和包衣材料对肝脏代谢的影响。

Clearance of iron oxide particles in rat liver: effect of hydrated particle size and coating material on liver metabolism.

作者信息

Briley-Saebo Karen C, Johansson Lars O, Hustvedt Svein Olaf, Haldorsen Anita G, Bjørnerud Atle, Fayad Zahi A, Ahlstrom Haakan K

机构信息

Imaging Science Laboratories, Mount Sinai School of Medicine, New York, NY 10029, USA.

出版信息

Invest Radiol. 2006 Jul;41(7):560-71. doi: 10.1097/01.rli.0000221321.90261.09.

DOI:10.1097/01.rli.0000221321.90261.09
PMID:16772849
Abstract

OBJECTIVES

We sought to evaluate the effect of the particle size and coating material of various iron oxide preparations on the rate of rat liver clearance.

MATERIALS AND METHODS

The following iron oxide formulations were used in this study: dextran-coated ferumoxide (size = 97 nm) and ferumoxtran-10 (size = 21 nm), carboxydextran-coated SHU555A (size = 69 nm) and fractionated SHU555A (size = 12 nm), and oxidized-starch coated materials either unformulated NC100150 (size = 15 nm) or formulated NC100150 injection (size = 12 nm). All formulations were administered to 165 rats at 2 dose levels. Quantitative liver R2* values were obtained during a 63-day time period. The concentration of iron oxide particles in the liver was determined by relaxometry, and these values were used to calculate the particle half-lives in the liver.

RESULTS

After the administration of a high dose of iron oxide, the half-life of iron oxide particles in rat liver was 8 days for dextran-coated materials, 10 days for carboxydextran materials, 14 days for unformulated oxidized-starch, and 29 days for formulated oxidized-starch.

CONCLUSIONS

The results of the study indicate that materials with similar coating but different sizes exhibited similar rates of liver clearance. It was, therefore, concluded that the coating material significantly influences the rate of iron oxide clearance in rat liver.

摘要

目的

我们试图评估各种氧化铁制剂的粒径和包衣材料对大鼠肝脏清除率的影响。

材料与方法

本研究使用了以下氧化铁制剂:葡聚糖包被的铁氧化物(粒径 = 97 nm)和铁葡聚糖-10(粒径 = 21 nm)、羧基葡聚糖包被的SHU555A(粒径 = 69 nm)和分级的SHU555A(粒径 = 12 nm),以及氧化淀粉包被的材料,未配制的NC100150(粒径 = 15 nm)或配制的NC100150注射液(粒径 = 12 nm)。所有制剂均以2种剂量水平给予165只大鼠。在63天的时间段内获取肝脏定量R2*值。通过弛豫测量法测定肝脏中氧化铁颗粒的浓度,并使用这些值计算颗粒在肝脏中的半衰期。

结果

给予高剂量氧化铁后,葡聚糖包被材料在大鼠肝脏中氧化铁颗粒的半衰期为8天,羧基葡聚糖材料为10天,未配制的氧化淀粉为14天,配制的氧化淀粉为29天。

结论

研究结果表明,具有相似包衣但不同粒径的材料表现出相似的肝脏清除率。因此,得出结论:包衣材料显著影响大鼠肝脏中氧化铁的清除率。

相似文献

1
Clearance of iron oxide particles in rat liver: effect of hydrated particle size and coating material on liver metabolism.大鼠肝脏中铁氧化物颗粒的清除:水合粒径和包衣材料对肝脏代谢的影响。
Invest Radiol. 2006 Jul;41(7):560-71. doi: 10.1097/01.rli.0000221321.90261.09.
2
Long-term imaging effects in rat liver after a single injection of an iron oxide nanoparticle based MR contrast agent.单次注射基于氧化铁纳米颗粒的磁共振造影剂后大鼠肝脏的长期成像效应。
J Magn Reson Imaging. 2004 Oct;20(4):622-31. doi: 10.1002/jmri.20175.
3
Hepatic cellular distribution and degradation of iron oxide nanoparticles following single intravenous injection in rats: implications for magnetic resonance imaging.大鼠单次静脉注射后氧化铁纳米颗粒的肝细胞分布及降解:对磁共振成像的意义
Cell Tissue Res. 2004 Jun;316(3):315-23. doi: 10.1007/s00441-004-0884-8. Epub 2004 Apr 23.
4
Studying the effect of particle size and coating type on the blood kinetics of superparamagnetic iron oxide nanoparticles.研究粒径和涂层类型对超顺磁性氧化铁纳米颗粒血液动力学的影响。
Int J Nanomedicine. 2012;7:4447-58. doi: 10.2147/IJN.S33120. Epub 2012 Aug 10.
5
Cell tagging with clinically approved iron oxides: feasibility and effect of lipofection, particle size, and surface coating on labeling efficiency.使用临床批准的氧化铁进行细胞标记:脂质转染、粒径和表面涂层对标记效率的可行性及影响
Radiology. 2005 Apr;235(1):155-61. doi: 10.1148/radiol.2351040094. Epub 2005 Mar 4.
6
Real-time imaging of convection-enhanced delivery of viruses and virus-sized particles.对流增强递送病毒和病毒大小颗粒的实时成像。
J Neurosurg. 2007 Sep;107(3):560-7. doi: 10.3171/JNS-07/09/0560.
7
Magnetic iron oxide particles coated with carboxydextran for parenteral administration and liver contrasting. Pre-clinical profile of SH U555A.用于肠胃外给药和肝脏造影的羧基葡聚糖包被的磁性氧化铁颗粒。SH U555A的临床前概况。
Acta Radiol. 1997 Jul;38(4 Pt 1):584-97. doi: 10.1080/02841859709174391.
8
Biodistribution of ultrasmall iron oxide particles in the rat liver.超小氧化铁颗粒在大鼠肝脏中的生物分布。
J Magn Reson Imaging. 2001 Apr;13(4):594-9. doi: 10.1002/jmri.1083.
9
Biodegradation of magnetite dextran nanoparticles in the rat. A histologic and biophysical study.大鼠体内磁铁矿葡聚糖纳米颗粒的生物降解。一项组织学和生物物理学研究。
Lab Invest. 1994 Dec;71(6):895-903.
10
Transferrin receptor upregulation: in vitro labeling of rat mesenchymal stem cells with superparamagnetic iron oxide.转铁蛋白受体上调:用超顺磁性氧化铁对大鼠间充质干细胞进行体外标记
Radiology. 2007 Aug;244(2):514-23. doi: 10.1148/radiol.2442060599. Epub 2007 Jun 11.

引用本文的文献

1
Protection of Hearing Loss in Ototoxic Mouse Model Through SPIONs and Dexamethasone-Loaded PLGA Nanoparticle Delivery by Magnetic Attraction.通过磁吸引递送 SPIONs 和载地塞米松的 PLGA 纳米颗粒保护耳毒性小鼠模型中的听力损失。
Int J Nanomedicine. 2022 Dec 13;17:6317-6334. doi: 10.2147/IJN.S380810. eCollection 2022.
2
Engineering of inorganic nanoparticles as magnetic resonance imaging contrast agents.作为磁共振成像造影剂的无机纳米颗粒工程
Chem Soc Rev. 2017 Nov 27;46(23):7438-7468. doi: 10.1039/c7cs00316a.
3
Molecular magnetic resonance imaging of activated hepatic stellate cells with ultrasmall superparamagnetic iron oxide targeting integrin αvβ₃ for staging liver fibrosis in rat model.
利用靶向整合素αvβ₃的超小超顺磁性氧化铁对大鼠模型肝纤维化进行分期时,对活化肝星状细胞的分子磁共振成像
Int J Nanomedicine. 2016 Mar 18;11:1097-108. doi: 10.2147/IJN.S101366. eCollection 2016.
4
In vivo delivery, pharmacokinetics, biodistribution and toxicity of iron oxide nanoparticles.氧化铁纳米颗粒的体内递送、药代动力学、生物分布及毒性
Chem Soc Rev. 2015 Dec 7;44(23):8576-607. doi: 10.1039/c5cs00541h. Epub 2015 Sep 21.
5
Magnetic Resonance Imaging of Atherosclerosis Using CD81-Targeted Microparticles of Iron Oxide in Mice.使用靶向CD81的氧化铁微粒对小鼠动脉粥样硬化进行磁共振成像
Biomed Res Int. 2015;2015:758616. doi: 10.1155/2015/758616. Epub 2015 Jul 21.
6
Molecular magnetic resonance imaging of brain-immune interactions.脑-免疫相互作用的分子磁共振成像
Front Cell Neurosci. 2014 Nov 27;8:389. doi: 10.3389/fncel.2014.00389. eCollection 2014.
7
Toxicity and Biodistribution of Activated and Non-activated Intravenous Iron Oxide Nanoparticles.活性与非活性静脉注射氧化铁纳米颗粒的毒性及生物分布
Proc SPIE Int Soc Opt Eng. 2009 Feb 12;7181:71810L. doi: 10.1117/12.809830.
8
Imaging of oxidation-specific epitopes with targeted nanoparticles to detect high-risk atherosclerotic lesions: progress and future directions.使用靶向纳米颗粒对氧化特异性表位进行成像以检测高危动脉粥样硬化病变:进展与未来方向
J Cardiovasc Transl Res. 2014 Nov;7(8):719-36. doi: 10.1007/s12265-014-9590-4. Epub 2014 Oct 9.
9
Delayed hepatic signal recovery on ferucarbotran-enhanced magnetic resonance images in a rat model with regional liver irradiation.在大鼠局部肝脏照射模型中,钆贝葡胺增强磁共振图像上肝脏信号延迟恢复。
MAGMA. 2014 Dec;27(6):501-8. doi: 10.1007/s10334-014-0434-7. Epub 2014 Feb 26.
10
biodistribution of iron oxide nanoparticles: an overview.氧化铁纳米颗粒的生物分布:概述
Proc SPIE Int Soc Opt Eng. 2011 Feb 22;7901:790117. doi: 10.1117/12.876414.